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Background: Intrapartum hypoxic events (“birth asphyxia”) 
may result in stillbirth, neonatal or postneonatal mortality, 
and impairment. Systematic morbidity estimates for the bur-
den of impairment outcomes are currently limited. Neonatal 
encephalopathy (NE) following an intrapartum hypoxic event 
is a strong predictor of long-term impairment.
Methods: Linear regression modeling was conducted on 
data identified through systematic reviews to estimate NE inci-
dence and time trends for 184 countries. Meta-analyses were 
undertaken to estimate the risk of NE by sex of the newborn, 
neonatal case fatality rate, and impairment risk. A compart-
mental model estimated postneonatal survivors of NE, depend-
ing on access to care, and then the proportion of survivors 
with impairment. Separate modeling for the Global Burden of 
Disease 2010 (GBD2010) study estimated disability adjusted life 
years (DALYs), years of life with disability (YLDs), and years of life 
lost (YLLs) attributed to intrapartum-related events.
results: In 2010, 1.15 million babies (uncertainty range: 
0.89–1.60 million; 8.5 cases per 1,000 live births) were esti-
mated to have developed NE associated with intrapartum 
events, with 96% born in low- and middle-income countries, 
as compared with 1.60 million in 1990 (11.7 cases per 1,000 
live births). An estimated 287,000 (181,000–440,000) neonates 
with NE died in 2010; 233,000 (163,000–342,000) survived with 
moderate or severe neurodevelopmental impairment; and 
181,000 (82,000–319,000) had mild impairment. In GBD2010, 
intrapartum-related conditions comprised 50.2 million DALYs 
(2.4% of total) and 6.1 million YLDs.
conclusion: Intrapartum-related conditions are a large 
global burden, mostly due to high mortality in low-income 
countries. Universal coverage of obstetric care and neonatal 
resuscitation would prevent most of these deaths and disabili-
ties. Rates of impairment are highest in middle-income countries 
where neonatal intensive care was more recently introduced, 
but quality may be poor. In settings without neonatal intensive 
care, the impairment rate is low due to high mortality, which is 
relevant for the scale-up of basic neonatal resuscitation.
over the last decade, with increasing focus on Millennium Development Goal (MDG) 4 for child survival, more 
scientific rigor has been applied to mortality estimation. 
Intrapartum-related hypoxic events, previously referred to as 
“birth asphyxia,” remain a major cause of global mortality, con-
tributing to almost one-quarter of the world’s 3 million neonatal 
deaths and almost half of 2.6 million third-trimester stillbirths 
(1,2). In previous Global Burden of Disease (GBD) estimates, 
“birth asphyxia” accounted for one of the highest numbers of 
disability adjusted life years (DALYs) for any single condition 
(3). However, estimates of the morbidity and impairment for 
this condition are constrained by several specific factors beyond 
the usual data gaps in low- and middle-income countries 
(LMICs), including shifting case definitions and terminology 
surrounding “birth asphyxia” (Table 1), difficulty in measuring 
impairment/disability, and the complexity of attributing cau-
sation to intrapartum insults, particularly when comorbidity 
such as infection or moderate preterm birth exists (4).
Early estimates of intrapartum-related neonatal mortality var-
ied considerably, reflecting the different case  definitions, data 
uncertainties, and changing estimation methodologies (Table 2) 
(4). The first systematic national estimates of intrapartum-related 
mortality were generated by Lawn et al. with the Child Health 
Epidemiology Reference Group (CHERG) using both single-
cause and multi-cause regression methods and resulted in  similar 
global totals of 904,000 (uncertainty range (UR): 650,000–
1,170,000) and 910,000 (600,000–1,080,000; Table 2) for the 
year 2000 (1,5). In the most recent Child Health Epidemiology 
Reference Group analysis (CHERG) using multi-cause model-
ing for 2010, there were an estimated 717,000 (610,000–876,000) 
intrapartum-related neonatal deaths (6). The mortality estimates 
undertaken by the Institute of Health Metrics and Evaluation and 
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used by GBD for 2010 (GBD2010) are generated using similar 
inputs but different methods (ensemble modeling) and estimated 
638,000 intrapartum-related deaths (517,000–798,000) in 1990 
and 510,000 deaths (400,000–620,000) in 2010 (7). In addition, 
there have now been two published systematic estimates of intra-
partum stillbirths; the most recent in The Lancet stillbirth series 
estimated 1.2 million stillbirths (0.66–1.48) in 2009 (1,8). In total, 
there are ~2 million deaths (maternal, fetal, and neonatal) annu-
ally related to intrapartum complications, and they occur almost 
entirely in LMICs (1,2).
However, there are no systematic estimates with detailed 
methods for intrapartum-related impairment outcomes, which 
also carry a heavy burden and lifelong consequences for fami-
lies. Such outcomes are increasingly important to measure and 
address as mortality begins to decline. The post–MDG dia-
logue emphasizes health and sustainable development as well 
as survival. The World Health Organization (WHO) World 
Health Report 2005 estimated that annually as many as 1 mil-
lion survivors of “birth asphyxia” may develop cerebral palsy, 
learning difficulties or other disabilities (9), although detailed 
methods were not published. GBD DALYs consist of years of 
life lost (YLLs) to premature mortality and years of life with 
disability (YLDs). The first GBD estimated that “birth asphyxia” 
was responsible for 16.9 million DALYs (3.5 million YLDs 
and 13.4 YLLs) in 1990 (3,10). The GBD2008 update (for the 
year 2004) used different methods and estimated that “birth 
asphyxia” was responsible for 42 million DALYs (12.9 million 
YLDs in LMICs), which was double that due to diabetes and 
almost three-quarters of the burden due to HIV/AIDS (58 mil-
lion DALYs), although no methods were published regarding 
the “asphyxia” estimates (Table 2).
The GBD2010 Expert Team for Intrapartum-related 
Neonatal Conditions overlaps with the author group on this 
paper. After the inputs were finalized for GBD2010, further 
data have been published and became available for analyses, 
including the coverage of care assumptions used throughout 
this supplement. The current analyses are in the spirit of con-
tinually improving the input data. Inputs or methods deviating 
from GBD2010 will be noted (11).
The overall objective of this work was to estimate the burden 
of neonatal impairment related to intrapartum-related hypoxic 
events. Neonatal encephalopathy (NE) following intrapartum 
events is a strong predictor of long-term impairment. In this manu-
script, we detail the modeling process, input parameters, and esti-
mation outputs for the following three-step compartmental model:
1. Incidence of NE related to intrapartum events at the 
national, regional, and global level for the year 2010, 
with time trends since 1990,
2. Neonatal case fatality rate (CFR) in order to estimate a 
cohort of affected survivors,
3. Risk of long term impairment in survivors, including 
both moderate–severe and mild neurodevelopmental 
impairment (NDI).
table 1. Paradigm shifts in the language of “birth asphyxia” 
Measures of intrapartum-related hypoxia
  Over the past decades, there has been a paradigm shift in the terminology surrounding “birth asphyxia,” in order to better define, clarify, and measure 
the condition (1,4,147). Measures of intrapartum-related hypoxia may be categorized into three clusters of terms: process-based indicators (i.e., measures 
of abnormal obstetric processes such as obstructed labor, breech presentation), clinical sign-based indicators (i.e., low Apgar scores, fetal acidosis), and 
outcome-based indicators (i.e., fetal-neonatal mortality or morbidity) (4). Process-based indicators of “birth asphyxia” are difficult to measure/standardize; 
surrogate measures of abnormal obstetric processes (such as fetal heart monitoring or acidosis) are insensitive, nonspecific, and unfeasible in most of the 
developing world. Previously, symptom-based measures, such as the Apgar score, were commonly used to define “birth asphyxia.” However, the Apgar score 
was developed to indicate the success of a newborn’s transition to extrauterine life, not to measure the burden of disease attributable to intrapartum-related 
hypoxia. Numerous studies have demonstrated its limitations, such as lack of specificity and low positive predictive value for long-term outcomes (22,148,149).
recent changes in measurement
  Recently, epidemiologic measurement of intrapartum-related injury has shifted to outcome-based measures of intrapartum-related mortality and 
morbidity. Outcomes have usually been defined though multiple indicators, such as intrapartum stillbirths weighing over 1,000 g and NE, a syndromic 
diagnosis of a baby with impaired consciousness and neurobehavioral symptoms. These outcomes have improved correlation with etiology and long-
term prognosis (1,2).
consensus on “birth asphyxia” terminology
  Three consensus statements released by the American Academy of Pediatrics, American College of Obstetrics and Gynecology, and International 
Cerebral Palsy Task Force address the terminology and diagnosis of “birth asphyxia,” recommending against the use of the term “birth asphyxia” 
unless there is clear evidence of intrapartum-related causation (23,24,150). The terms “post-asphyxial encephalopathy” and “hypoxic ischemic 
encephalopathy” describe encephalopathy associated with intrapartum injury, although several recent consensus statements and an editorial have 
also cautioned against the use of these terms unless there is very clear evidence of intrapartum causation (such as neuroimagining and/or arterial 
umbilical cord acidosis) (13,22–26). The term “neonatal encephalopathy” (NE) is now recommended (26). These statements are designed to clarify 
the medico-legal issues in determining cause and liability for perinatal brain injury in industrialized settings, where obstetric-neonatal care is rarely 
inadequate. However, acute hypoxic ischemia is still considered the most common etiology of NE even in high-income settings, accounting for 50–80% 
of NE cases based on clinical, EEG, and magnetic resonance imaging criteria (27). In low- and middle-income settings where recognition of intrapartum 
events and prompt intervention may be limited in health facilities, and over half of births occur in homes and without skilled birth attendants, the 
probability of intrapartum hypoxic events contributing to NE is much higher.
ne staging
  NE staging, or grading, was originally described in three stages by Sarnat et al. in 1976 and included clinical and EEG findings. Several subsequent 
classifications for NE have been described in the literature and are shown in supplementary information online. Two scoring systems have been 
modified for use in developing country settings (Ellis et al. (49), Capetown scoring (17)), and one simplified classification developed by Badawi et al. (54) 
may be more feasible for use in low-resource settings (shown in supplementary information online). See table 4 for description of Sarnat staging.
EEG, electroencephalogram; NE, neonatal encephalopathy.
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In our parallel analyses for GBD2010, the following addi-
tional parameters were estimated: prevalence of impairment 
due to NE by age, YLDs, YLLs, and DALYs.
Methods
Definitions and Measurement
Figure 1 illustrates the pathways and adverse outcomes related to 
intrapartum complications, and Table 3 defines the epidemiologic 
terminology used in this paper. The language used for this con-
dition and related outcomes has changed over time as a result of 
clarification of the epidemiology as well as concerns over litigation 
(Table 1).
“Birth asphyxia” was broadly defined by the WHO as “failing to 
initiate or maintain regular breathing at birth” (12). This clinical 
diagnosis is commonly referred to as neonatal respiratory  depression 
and indicated by low Apgar scores, which were intended to be sensi-
tive and nonspecific (Figure 1). “Asphyxia” was commonly assumed 
to result from insults during pregnancy and childbirth, with asso-
ciated hypoxia and metabolic acidosis (4). However, neonatal 
respiratory depression may have other etiologies such as preterm 
birth, infection, maternal analgesia, congenital malformations, or 
table 2. Previous estimates of intrapartum-related outcomes (“birth asphyxia”) 
estimation year
intrapartum 
stillbirths
intrapartum-related 
neonatal deaths
intrapartum-related neonatal 
disability
source  
(reference number)
1991 — 800,000 “At least an equal number” to the 800,000 
neonatal deaths
WHO (151)
1996 (for 1990) Not assessed 398,000 (assumes mortality 
due to ‘birth asphyxia’ of 1.51 
per 1,000 for developing 
regions)
Cases/year not specified WHO GBD I  (10)
3,525,000 y of life disabled (assumes rate 
per year of disability between 0.75 and 7.5 
per 1,000 for all categories of disability)
16.1 million DALYs
1996 (for 1990) — 1.6 million (of 5.0 million 
neonatal deaths, 32% due to 
asphyxia/birth injuries)
Not assessed WHO Reproductive 
Health and Research 
(152)
2001 (for 1999) — 1.16 million (of 4.0 million 
neonatal deaths, 29% due to 
birth asphyxia)
Not assessed WHO Reproductive 
Health and Research 
(153)
2001 1.95 million (50% 
of 3.9 million 
stillbirths)
— Not assessed WHO Reproductive 
Health and Research 
(154)
Making Pregnancy Safer
2001 (for 2000) Not assessed 788,000 33,691,000 DALYs WHO GBD I (155)
Males 427,000 7,565,000 y of life disabled
Females 360,000 Methods not published
2002 (for 2001) — 689,694 33,823,855 DALYs WHO GBD (156)
2003–2004 (for 2002) — 723,418 34,445,758 DALYs WHO GBD (157)
2005 (for 2000) 1.02 (0.66–1.48) 
million
904,000  
(650,000–1.17 million)
Not assessed Lawn, Shibuya, and 
Stein (1)
2005 Not assessed — 1 million survivors with 
neurodevelopmental delay
WHO World Health 
Report, no data inputs or 
methods provided (9)
2006 (for 2000) Not assessed 910,000  
(range 600,000–1.08 million)
Not assessed Lawn, Wilczynska-
Ketende, and Cousens 
(5)
2006 (for 2001) — 728,000 31.4 million DALYs WHO GBD  (158)
9.5 million YLDs
2008 (for 2004) Not assessed 856,535 41,683,855 DALYs WHO GBD (159)
12.9 YLDs LMICs
2011 (for 2008) 1.2 million (range 
0.82–1.97 million)
Not assessed Not assessed Lawn et al.  (8)
2012 (for 2010 with time 
trends 2000–2010) 
Not assessed 717,000  (610,000–876,000) Not assessed Liu et al.  (6)
GBD2010 with time 
trends 1990–2010
Not assessed 510,000  (400,000–620,000) 50,150,000 DALYs (40,521,000–
59,841,000) 6.1 million YLDs
Lancet GBD series, 
using the work in this 
supplement  (7,41)
The methods for calculating the DALY metric in GBD2010 changed from previous GBD studies. Notably, discounting and age weighting were removed, prevalence-based YLDs were 
estimated, and a higher standard life table was used as reference.
DALYs, disability adjusted life years; GBD, Global Burden of Disease; LMIcs, low- and middle-income countries; YLDs, years lived with disability.
Source: updated from Lawn (2009) (4).
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metabolic disorders and is not predictive of long-term outcomes. In 
low-resource settings with poor intrapartum care and low access to 
neonatal resuscitation, some of these nonbreathing babies will die 
immediately in the delivery room or within a few hours of life.
For those infants suffering a severe hypoxic event who do not die 
immediately, some infants will develop NE—a “disturbance of neu-
rological function in the earliest days of life (onset: 1–3 d of life) 
in the term infant manifested by difficulty initiating and maintain-
ing respiration, depression of tone or reflexes, abnormal level of 
consciousness, and often by seizures” (13). Staging of NE was first 
defined by Sarnat and Sarnat (14) using clinical and electroencepha-
logram criteria, with classification into mild, moderate, and severe 
stages (Table  4). Subsequently several other clinical classifications 
have been used (14–19) (Supplementary Information online). NE 
is strongly predictive of long-term impairment (20,21) and clearer 
to diagnose than neonatal respiratory depression, and impairment 
after an intrapartum hypoxic insult is uncommon in the absence of 
NE. For those reasons, our estimates use NE as the starting point to 
estimate long-term impairment associated with intrapartum hypoxic 
events, rather than neonatal respiratory depression or low Apgar 
score (Figure 1).
The terms “post-asphyxial encephalopathy (PAE)” and “hypoxic 
ischemic encephalopathy (HIE)” have been frequently used since 
the 1970s to refer to encephalopathy associated with intrapartum 
injury. Given the possibility of other causes and difficulty in prov-
ing causation, the term NE is now preferred, and several recent con-
sensus statements and an editorial have cautioned against the use of 
the terms PAE and HIE (13,22–26). HIE may be used when there 
is very clear evidence of intrapartum insult including low arterial 
cord blood pH, neuroimagining consistent with hypoxic–ischemic 
insult, and depressed Apgar score (27), although this is still con-
troversial. Furthermore, the extent to which infectious disease may 
exacerbate intrapartum events and perinatal brain injury (double hit 
hypothesis) remains to be fully described (28). Estimates of the con-
tribution of intrapartum events to NE are varied. In studies requir-
ing stringent clinical criteria and neuroimaging (magnetic reso-
nance imaging, electroencephalogram), the contribution of hypoxic 
events ranges between 50 and 80% (29–31) and is presumably the 
most common cause, even in these high-income settings (27). 
In an Australian population–based study using a broad clinical defi-
nition of NE, the intrapartum contribution was as low as 30% (16). 
However, in low-resource settings with poor intrapartum care, the 
proportion of NE attributable to intrapartum-related events is likely 
to be at the higher end of the range. For example, in a maternity hos-
pital in Nepal, evidence of intrapartum compromise preceded 68% of 
cases (30). Given the 50 million annual home births and poor quality 
of obstetric care even in facility births in many LMICs, the majority 
of NE at the global level is associated with intrapartum complica-
tions—which we refer to as “NE related to intrapartum events” in 
this paper.
We estimated long-term, mild, and moderate-to-severe neurode-
velopmental impairment (NDI) NDI following NE, including motor 
and/or cognitive-intellectual impairments. Impairment categories 
and definitions were standardized per the CHERG neonatal morbid-
ity expert group and described in detail in the methods paper in this 
supplement (11) and are defined in Table 3. For intervention trials, 
we used impairment rates from control arms, given that the interven-
tions (primarily therapeutic hypothermia) are not yet implemented as 
the standard of care in most regions of the world.
Searches and Data Sources
We systematically reviewed the literature with no date restrictions 
until November 2009 for the GBD2010 project (Supplementary 
Information online). The searches were updated in October 2012 
and identified new data previously not included in GBD2010. The 
following databases were searched without language restrictions but 
limited to “human subjects”: Medline, Popline, Cochrane, EMRO, 
EMBASE, Web of Science, LILACS (Latin American and Caribbean 
Health Sciences Literature), and African Index Medicus. The search 
terms included “neonatal encephalopathy” and “hypoxic ischemic 
encephalopathy.” Snowball searching added literature referenced in 
key papers. Furthermore, abstracts from pediatric conference pro-
ceedings were searched for relevant data. Extensive efforts were also 
made to contact investigators and program managers for unpublished 
data, particularly in low–middle-income settings.
Inclusion/Exclusion Criteria and Data Abstraction
Titles and abstracts were reviewed; studies that reported data on inci-
dence, prevalence, NE staging, case fatality, or impairment/morbid-
ity associated with NE were abstracted. Studies without such data 
but reporting the number of NE cases were included if the principal 
investigator could be contacted and precise data regarding the size of 
Figure 1. Global burden of disease schematic for intrapartum-related events “birth asphyxia.” See table 4 for clinical definitions pertaining to intrapar-
tum-related events.
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the original birth cohort obtained. Studies meeting preliminary inclu-
sion criteria were excluded if:
1. they did not limit the NE definition to full-term infants (13),
2. selection of the birth cohort or NE cases was not clearly 
defined,
3. substantial selection biases existed or cases were drawn from a 
specialized subpopulation,
4. they reported the same data from a previously included cohort, 
or 
5. median birth year of the study cohort was before 1980.
We did not examine Apgar score as an outcome since Apgar score 
is an unreliable indicator of mortality and long-term morbidity 
(32,33). Due to selection bias in intervention trials, data from inter-
vention studies were not included for the incidence or case fatality 
analysis.
Data were abstracted into a standard form and rechecked by a 
second investigator. Study characteristics were abstracted with 
regard to the study identifiers, context, design, and limitations. 
The following NE-related data were summarized: case definition; 
evidence of intrapartum-related events/insult; exclusion criteria, 
incidence (numerator of term-NE cases diagnosed, denominator of 
total live births in the same period); proportion of NE cases clas-
sified as mild (stage 1), moderate (stage 2), and severe (stage 3); 
neonatal case fatality (overall and by stage); and long-term impair-
ment (overall and by stage). Neonatal mortality levels were defined 
as NMR level 1: <5 neonatal deaths/1,000 live births; NMR level 2: 
5 to <15 neonatal deaths/1,000 live births; and NMR level 3: ≥15 
neonatal deaths/1,000 live births (11).
Modeling Approach
A three-step compartment model was applied, including the input 
parameters and process to estimate firstly NE incidence, secondly 
the proportion of those with NE who survive the neonatal period, 
and thirdly the proportion of those survivors of NE who survive with 
impairment (Figure 2). Analyses were performed using Stata version 
12 (StataCorp LP, College Station, TX).
Step 1: estimation of NE incidence by statistical  modeling. The 
NE risk was modeled using linear regression with random effects 
using the GBD region as the cluster unit. A total of 40 data inputs 
were included in the modeling, with observations from 26 coun-
tries, with median study years ranging from 1980 to 2010. National 
predictor variables were tested that might plausibly predict the risk 
table 3.  Definitions of clinical outcomes pertaining to intrapartum-related events 
outcome definition icd-10 codes
Intrapartum-related 
stillbirth
A stillborn baby (shows no signs of life at delivery and weighs more than 500 g or is greater than 22 wk 
of gestation) with intact skin and no signs of disintegration in utero. The death is assumed to have 
occurred in the 12 h before delivery and was most likely due to an intrapartum hypoxic event. Babies 
with severe congenital abnormalities are not included (based on Wigglesworth's classification) (1).
P017 to P019, P030 to P039
P95 covers fetal death 
unspecified
Intrapartum-related 
neonatal deaths 
(previously called 
“birth asphyxia” 
deaths)
Neonatal deaths of term babies with neonatal encephalopathy (NE) (see below) or who cannot be 
resuscitated (or for whom resuscitation is not available). Where possible, other causes should be 
excluded such as lethal congenital malformations and preterm birth complications (less than 34 
completed weeks of gestation or birth weight <2,000 g).
P210 to P210: Hypoxic 
ischemic encephalopathy
P100 to P150: Birth injury; 
P240: Meconium 
aspiration
“Non-breathing baby” 
Neonatal respiratory 
depression
Infant with neonatal respiratory depression after birth that may be due to any of a multitude of 
causes, including but not restricted to intrapartum hypoxia, respiratory distress syndrome–preterm 
birth, infection, general anesthesia during labor, meconium aspiration, intracranial disease, and 
neuromuscular disease. These infants have low Apgar scores.
P210 to P219
Neonatal 
encephalopathy (NE)
“A disturbance of neurological function in the earliest days of life in the term infant manifested by 
difficulty initiating and maintaining respiration, depression of tone and reflexes, abnormal level of 
consciousness and often by seizures” (14,62), which may follow an intrapartum hypoxic insult or be 
due to another cause. NE is usually separated into three grades (mild, moderate, severe) by clinical 
findings during the first week of life. Virtually all babies with mild NE who are normal at the end of the 
first week of life will be free of long-term neurological damage. The majority of infants with severe NE 
will die or manifest severe neurological impairment.
P210 to P219
P910 to P919
Hypoxic ischemic 
encephalopthy (HIE)
A syndrome of abnormal neurological behavior in the neonate, which is frequently associated with 
multi-system dysfunction and follows severe injury before or during delivery. There are several 
systems for categorizing HIE (most commonly into mild, moderate, severe). Most authorities now 
prefer the term NE and then specifying if the encephalopathy is associated with intrapartum injury.
P210 to P219: Hypoxic 
ischemic encephalopathy
Cerebral palsy A non-progressive disorder of motor function, which may originate during pregnancy, delivery, or 
in the postnatal period.
Moderate-to-severe 
neuro developmental 
impairment (NDI)
One or more of the following: International Classification 
of Functioning, 1999 (i) Cognitive delay with developmental quotient Z-score <−2SD for test (<70)
 (ii) Motor delay: Either
   Moderate: Difficulty in holding implements, dressing, and sitting upright. Able to move 
around with help.
  Severe: Inability to walk and absence of functional use of hands.
 (iii) Any three domains mildly affected
Mild 
neurodevelopmental 
impairment (NDI)
Either mild cognitive delay with developmental quotient −1SD to −2SD for test (70–84) or mild motor 
delay: difficulty in everyday motor activities, but able to move around without help.
International Classification 
of Functioning, 1999
Adapted from ref. 2.
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table 4. Original Sarnat staging of NE (14)
level of  
consciousness
stage 1 (mild) stage 2 (moderate) stage 3 (severe)
hyperalert lethargic/obtunded stuporous
Neuromuscular control
 Muscular tone Normal Mild hypotonia Flaccid
 Posture Mild distal flexion Strong distal flexion Intermittent decerebration
 Stretch Overactive Overactive Decreased/absent
 Segmental myoclonus Present Present Absent
Complex reflexes
 Suck Weak Weak/absent Absent
 Moro Strong Weak Absent
 Oculovestibular Normal Overactive Weak/absent
 Tonic neck Slight Strong Absent
Autonomic function
 Pupils Mydriasis Miosis Variable
 Heart rate Tachycardia Bradycardia Variable
  Bronchial/salivary  
secretions
Sparse Profuse Variable
 Gastrointestinal motility Normal/decreased Increased/diarrhea Variable
Seizures None Common/focal or multifocal Uncommon
EEG Normal/decreased Early low voltage continuous delta 
and theta, later periodic,  
seizues focal 1–1.5 Hz spike-wave
Early periodic pattern with 
isopotential phases, later 
isopotential
Duration <24 h 2–14 days Hours–weeks
EEG, electroencephalogram.
Figure 2. Compartmental model: parameters required and methods for estimation of the global burden of impairment related to intrapartum-related 
events and neonatal encephalopathy.
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of NE. The covariates tested included: biologic/demographic fac-
tors (NMR, stillbirth rate, low-birth-weight prevalence, HIV preva-
lence); health care access (cesarean section rate, skilled birth atten-
dance, DPT3 coverage); and socioeconomic/geographic factors 
(GDP, urbanization, female literacy). Natural logarithms were used 
to transform continuous variables and log-odds to proportions to 
stabilize  variance (1,34). Data points were evaluated for leverage 
by visual inspection of residual vs. fitted plots using Cook’s D sta-
tistic, and extreme outlying/leverage studies (35,36) were excluded 
(Cook’s D: >4/n).
Dummy variables were tested to control for:
1. NE definition quality, i.e., “good” (clear case definition consis-
tent with NE and indication of history of intrapartum-related 
events) or “poor” (poorly defined criteria and/or not restricted 
to intrapartum-related “birth asphyxia”),
2. severity, i.e., studies reporting incidence of moderate-to-severe 
grade only (instead of all grades),
3. population selection bias, i.e., population-based sample vs. 
data presenting selection bias (facility-based, tertiary care hos-
pital, or neonatal intensive care unit cohort), and
4. study decade.
Models were tested with individual predictors, and additional 
potential models were developed using automatic forward and 
backward stepwise selection (significance level of P < 0.10). Models 
were compared with respect to adjusted R2, Akaike’s Information 
Criterion, and out-of-model prediction accuracy. Prediction 
accuracy was calculated using cross validation methods similar 
to the approach described by Liu et al. (37). Study data were ran-
domly divided into five subsamples. One subsample was withheld 
while modeling was conducted on the remaining 80% of the data. 
A standardized error term was calculated as (observed(ln NE) − 
predicted(ln NE))2 on the excluded 20%. This was repeated with 
each successive subsample withheld, and a summary measure of 
the prediction error was generated for the entire data set. The final 
model selected was that which had the lowest overall prediction 
error based on the standardized error term and estimated by the 
following equation:
ln NE  Def X  Y( )ijt k ijk m ijm p itp i it= + + + + +∑ ∑ ∑α γ λ η εβ
where i is country; j is source; t is median year of study; Def is a set 
of NE case definition dummy variables; X is set of dummy variables 
for population selection/bias; Y is set of predictor variables represent-
ing socioeconomic factors and health care utilization for country (i) 
and year (t); ε is normally distributed error term; and η, normally 
distributed regional random effect.
National incidence of NE was predicted for 184 countries using 
the final model and multiplied by the number of live births in 2010 
to obtain the estimated number of cases of NE (38). For the analysis 
of time trends, national covariate data were used for NMR (39) and 
births for the years 1990 and 2000 (38). We generated uncertainty 
estimates by drawing 1,000 bootstrapped samples from the modeling 
data set and repeated this for each step of the estimation process. For 
each bootstrapped sample, we ran the model and generated a new set 
of predicted national estimates for the prevalence of NE, including 
random effects at the regional level. For national-level estimates, we 
took the 2.5 and 97.5 centiles of the 1,000 predictions for our uncer-
tainty bounds. To obtain uncertainty ranges for regional- and global-
level estimates, we summed the relevant national estimates derived 
from each bootstrap sample, again taking the 2.5 and 97.5 centiles of 
the resulting distributions.
Steps 2–3: estimation of NE-related impairment using a com-
partmental model. In step 2, we estimated the number of postneo-
natal survivors and in step 3, the number of these survivors who 
were estimated to be impaired (Figure 2) for the year 2010. For the 
purpose of these estimates, and to be consistent with the other esti-
mates in this supplement (11), studies were grouped by NMR level 
(study or national NMR of the median study year) reflecting similar 
settings in terms of access to and quality of care.  Meta-analysis with 
random effects was used to calculate pooled proportions according 
to NMR level.
The following equation was used:
Number NEimpaired  
= number NE 1 - neonatal case fatality
( )
( )× NMR level
NMR level% survivors with impairment
( )
×( )
Uncertainty was calculated by taking 1,000 random draws from 
a normal distribution for the proportion derived from the meta- 
analysis at each step of the compartmental model.
GBD2010 Estimation of YLDs, YLLs, and DALYs
GBD2010 used a similar approach as the three steps above to esti-
mate the number of impaired NE survivors. The main differences in 
GBD2010 were (i) estimation of years 1990–2010 (vs. compartmen-
tal model 2010 only), (ii) data inputs (GBD2010 literature review 
completed in 2009 with fewer included studies), and (iii) assump-
tions in NE incidence modeling as GBD2010 did not include 
regional random effects or corrections for NE definition variation. 
After estimating the number of impaired survivors, GBD2010 per-
formed the following further steps to calculate YLDs, YLLs, and 
DALYs using input data and assumptions as detailed in the results 
section (7,40,41). A Bayesian meta-regression method DisMod-MR 
was used to  estimate the prevalence of long-term impairments by 
age, sex, and country (11) over each year during 1990–2010.
YLDs at all ages were calculated as the prevalence of impaired sur-
vivors at all ages multiplied by the disability weights derived for the 
GBD2010 study (11,42). Moderate-to-severe impairment outcomes 
were modeled together. This combines a range of health states, each 
with their own disability weight (11,42). An Australian register of 32 
children with cerebral palsy following NE was used to apportion the 
distribution of severity to motor impairment, cognitive impairment, 
seizure disorder, blindness, and all possible combinations of these 
(43). The final disability weight used for moderate-to-severe NDI for 
high-income regions was 0.38 (uncertainty range: 0.29–0.49) and 0.42 
(uncertainty range: 0.32–0.53) in low- and middle-income regions. 
The higher disability weights in low- and middle-income regions are 
because the epilepsy disability weights distinguish those with and 
without treatment differently.
DALYs at all ages were then calculated as the sum of YLLs and 
YLDs due to intrapartum complications (11,40). YLLs were calcu-
lated for the GBD2010 study using the Cause of Death Ensemble 
model and standard life expectancy tables (11,41) The total DALYs 
were calculated as the sum of the YLDs and YLLs attributable to 
NE (7,44).
results
Input Parameters and Estimates
The parameters and process of each step (Figure 2) are detailed 
with a short summary of the results. A summary of the input 
parameters is shown in Table 5, with study-specific details in 
the Supplementary Information online, and a summary of 
regional results in Table 6.
A total of 3,701 articles on NE/hypoxic ischemic encepha-
lopathy (HIE) were identified from the databases searched 
and two unpublished data sets were included (Supplementary 
Information online). After initial screening of title and/or 
abstract, there were 132 studies remaining, of which 80 met 
inclusion criteria. Data were used for NE incidence from 40 
studies, sex ratio from 14, neonatal case fatality from 33, and 
long-term impairment from 45 studies.
56 Pediatric RESEARch     Volume 74  |  Number s1  |  December 2013  copyright © 2013 International Pediatric Research Foundation, Inc.
Beyond survival: neonatal encephalopathy         Articles
table 5. Summary of data published on the incidence, grading, neonatal case fatality, and impairment of neonatal encephalopathy by CHERG 
NMR levels (1980–2013) 
countries according to level of nMr
nMr <5 nMr 5–<15 nMr ≥15
level 1 level 2 level 3
Number countries 2010 46 62 76
Number live births 2010 13,260,651 40,270,948 81,147,584
ST
EP
 1
NE incidence (per 1,000 
births)
12 countries 8 countries 8 countries
17 datasets 10 datasets 13 datasets
N = 3,232,480a N = 336,140a N = 777,104a
Median (range) Median (range) Median (range)
1.60 (0.68–3.75) 4.66 (1.44–10.20) 12.10 (3.64–26.51)
NE grade breakdown 9 countries 5 countries 7 countries
15 studies 6 studies 8 studies
Grade I: 39.2% (28.0–50.4%) Grade I: 30.0% (15.2–44.7%) Grade I: 42.2% (36.9–47.6%)
Grade II: 39.0% (30.9–47.1%) Grade II: 39.5% (28.2–50.7%) Grade II: 33.9% (27.8–40.0%)
Grade III: 21.7% (16.1–27.2%) Grade III: 28.6% (18.3–38.9%) Grade III: 24.0% (20.1–27.1%)
NE sex differential: 
proportion maleb
11 countries; 14 studies
n = 698 cases
58.7% (55.6–61.8%)
ST
EP
 2
NE 10 countries 5 countries 7 countries
NCFR (neonatal deaths/per 
100 incident cases)
14 studies 6 studies 11 studies
n = 995 cases n = 388 cases n = 1,256 cases
9.9% (7.9–11.9%) 10.7% (7.6–13.7%) 27.7% (18.7–36.6%)
Grade III: Grade III: Grade III:
8 countries 4 countries 5 countries
8 studies 5 studies 5 studies
n = 500 cases n = 370 cases n = 612 cases
76.8% (61.9–91.7%) 47.9% (36.2–59.5%) 91.8% (83.4–99.4%)
ST
EP
 3
Moderate-to-severe 
neurodevelopmental 
impairment outcomes after 
NE (per 100 postneonatal 
survivors of NE)
12 countries 12 countries
29 datasets 16 datasets
N = 1,482 survivors N = 858 survivors
Pooled estimate Pooled estimate
26.4% (22.1–30.8%) 26.9% (95% CI: 20.1–33.7%)
Time of assessment Time of assessment
6 mo–10 y 6 mo–12 y
Mild neurodevelopmental 
impairment after NE (per 
100 postneonatal survivors 
of NE)
6 countries 8 countries
8 datasets 9 datasets
N = 384 survivors N = 533 survivors
Pooled estimate Pooled estimate
14.0% (95% CI: 8.8–19.2%) 21.0% (95% CI: 9.8–32.2%)
Time of assessment Time of assessment
6 mo–16 y 1–10 y
aNot all studies indicated live birth denominator so underestimate of number of births represented. bAdjusted for population sex balance.
chERG, child health Epidemiology Reference Group; NcFR, neonatal case fatality rate; NE, neonatal encephalopathy; NMR, neonatal mortality rate.
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Step 1: Estimating the Incidence of NE
Data inputs. The studies included in the NE incidence analy-
sis are shown in Supplementary Information online. Most 
incidence data were facility based, with only seven studies 
reporting incidence from population-based birth registries, 
all in high-income settings. Few data were from Africa (n = 7 
studies) and South Asia (n = 5). Several studies reported NE 
incidence among full-term births only; these incidence rates 
were adjusted by dividing the incidence rate by the proportion 
of term births for the country and year (45). In one case, the 
HIE mortality rate (HIE deaths/live births) was reported (46), 
and the CFR was derived using a counterfactual of the national 
neonatal mortality rate (NMR) for that year. A limitation of 
the data was the variability of case definitions and inclusion 
criteria used to classify NE. Definitions of NE varied across 
studies: Sarnat (14), Fenichel (47), Levene (15), Badawi (16), 
International Classification of Diseases (ICD) codes, Amiel 
Tison (48), Ellis (49), Thompson Scoring (17), or other. Case 
inclusion differed with respect to the requirement for evidence 
of an “asphyxial” or “intrapartum insult.” The majority of stud-
ies (n = 18) required evidence of intrapartum hypoxia with a 
range of criteria from fetal distress, low Apgar scores with dif-
fering cutoffs/time of assessment (1 vs. 5 min), acidosis, meco-
nium, and/or need for neonatal resuscitation (Supplementary 
Information online).
The median NE incidence for NMR level 1 (NMR <5/1,000 
live births) was 1.60/1,000 live births (range: 0.68–3.75/1,000). 
Most data sets were from Western Europe and North America. 
There was an observed historical trend of decreasing incidence 
with increasing year of birth cohort in several high-income 
settings (Supplementary Information online: Derby, UK 
(50,51); Edinberg, UK (52); Sweden (53); and Perth, Australia 
(43,54)). For example, in the United Kingdom, the incidence 
of “HIE” in a large district health authority (Derby) decreased 
from 7.7/1,000 for 1976–1980, to 4.6/1,000 for 1984–1988, to 
1.9/1,000 for 1992–1996 (51).
Fewer data were available from higher mortality settings. 
For NMR level 2 (NMR 5-<15), the median incidence of 
NE was 4.66/1,000 live births (range: 1.44–10.20), whereas 
in NMR level 3 (NMR ≥15), the median NE incidence was 
12.10/1,000 live births (range: 3.64–26.51). It is very likely 
that these primarily facility-based incidence rates may under-
estimate NE incidence in high mortality settings in South 
Asia and Africa, where over half of births may occur outside 
of hospital facilities. There was only one community-based 
report of NE incidence from Nepal (55). Time trend data 
were available from the Indian National Perinatal Database. 
Incidence of NE did not change markedly between 1995 
and 2002 (56) (13.83 vs. 14.25/1,000 births, respectively) 
(Supplementary Information online).
The severity of NE was consistent across mortality levels 
(Table 5). The pooled proportion of the distribution of NE 
grade was: grade 1: 37.8% (31.0–44.6%)l; grade 2: 37.7% (32.9–
42.5%); and grade 3: 23.4% (19.9–27.0%). Given that separate 
meta-analyses were conducted for each grade, the sum of the 
pooled proportions does not equal 100.ta
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Regression modeling of NE incidence. The regression model 
shown in Table 7 was used to predict the natural log of the 
incidence of NE. Although meeting initial inclusion criteria, 
two data sets (35,36) were excluded due to extreme outly-
ing/leverage (Cook’s D: >4/n). The final model chosen used 
ln(NMR) as the main covariate and had the highest adjusted 
R2 (0.7457) and lowest prediction error. Dummy variables 
representing NE definition quality (including evidence of an 
intrapartum-related hypoxic insult), NE severity, and popula-
tion selection bias were retained to adjust for these variables. 
Figure 3 shows a plot of the natural log of the incidence of NE 
observed in the studies vs. those predicted by the regression 
model. Residuals were normally distributed (Supplementary 
Information online).
Sex differential among NE cases. Intervention studies were 
excluded from this analysis due to potential selection/recruit-
ment biases. There was a consistent predominance of male cases 
across NE birth cohorts in different regions and mortality levels 
(pooled proportion adjusted for population sex ratio at birth, 
58.7% males (55.6–61.8%)) (Supplementary Information 
online). The adjusted proportion of male cases ranged from 
48.5% in the Democratic Republic of Congo (57) to 70.6% in 
Italy (58). The NE sex risk ratios were adjusted for the live birth 
sex ratio for the year of the study, then pooled by random-effects 
meta-analysis. The sex-specific incidence was estimated by the 
following equation:  I RR * r *p r * (1 p), = + −  where I is inci-
dence, RR is risk of male sex, r is NE incidence among females, 
and p is proportion of male.
Although evidence supports increased risk for mortality and 
long-term impairment for male babies when compared with 
female babies, data were insufficient to include this in subse-
quent steps of the model after the sex-specific NE incidence 
risk.
Estimates of incident cases of NE. Globally, in 2010, there 
were an estimated 1.15 million (0.89–1.60 million) new 
cases of NE associated with intrapartum-related events 
table 7. Prediction model for the incidence of intrapartum-related NE 
description coefficient 95% confidence interval
NE definition quality Good NE case definition, and probable intrapartum event/etiology −0.1042 −0.5311, 0.3227
NE definition severity NE case definition grade moderate–severe only −0.0989 −0.6442, 0.4466
Hospital estimate  
(selection bias)
Dummy variable to identify facility-based rate in setting with low 
institutional birth rate
0.1016 −0.2882, 0.4919
Ln(NMR)* Natural log of NMR 0.8996 0.6598, 1.139
Constant −0.4952 −1.2760, 0.2855 
See Supplementary Information online for study data inputs and model residual distribution.
NE, neonatal encephalopathy; NMR, neonatal mortality rate.
*P < 0.05.
Figure 3. Modeling estimates of the incidence of intrapartum-related neonatal encephalopathy (NE): predicted values compared to observed values for 
study data inputs. See Supplementary Information online for details of the study data inputs.
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(686,000  male, 466,000 female), an incidence of 8.5/1,000 
live births (Figure 4). We estimate that 439,000 were grade 1 
(mild), 438,000 were grade 2 (moderate), 273,000 were grade 
3 (severe) NE. The majority of cases occurred in South–
Southeast Asia (532,000) and sub-Saharan Africa (478,000), 
which together accounted for more than 85% of incident 
cases. The highest regional incidence of NE was in sub- 
Saharan Africa (14.9/1,000 live births), followed by South 
Asia (10.4/1,000). In high-income regions, the incidence was 
as low as 1.5/1,000 live births.
Figure 4. Estimated incident cases of neonatal encephalopathy by region by the sex of the baby in 2010. White, male; black, female.
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Regional estimates of NE cases in 1990, 2000, and 2010 are 
shown in Figure 5. There were an estimated 1,604,000 cases 
of NE born worldwide in 1990 (global incidence: 11.7/1,000 
live births), which decreased to 1,380,000 in 2000 (10.6/1,000 
live births) and to 1,152,000 in 2010 (8.5/1,000 live births). 
There were reductions in the incidence of NE in all regions, 
with steeper drops in South Asia and East–Southeast Asia 
and Pacific. In sub-Saharan Africa, although there was a 
reduction in NE incidence from 18.3/1,000 live births in 1990 
to 14.9/1,000 in 2010, there was an estimated overall increase 
in the number of NE cases due to a substantial increase in 
the number of live births (23 million in 1990 to 32 million 
in 2010).
Step 2: calculation of the number of postneonatal Survivors 
after nE
Case fatality rate (CFR) by care available. A total of 31 
studies were included in the NE neonatal case fatality analy-
sis (Supplementary Information online). Two of the NMR 
level 1 studies were population-based surveillance studies 
(in Sweden (53,59)); the remaining 12 NMR level 1 studies 
were all conducted in tertiary care hospitals with neonatal 
intensive care. The NMR level 2 studies (n = 6) were from 
teaching hospitals with neonatal intensive care in middle-
income countries, or from higher income countries from 
the mid-1980s. In the highest mortality group (level 3, NMR 
≥15), all studies (n = 11) were from tertiary care hospitals, 
except for one community-based study from Nepal (55), 
where the neonatal CFR was substantially higher at 49%. 
Prehospital discharge case fatality was used in cases where 
neonatal CFR was not otherwise reported. In NMR level 1, 
the pooled neonatal case fatality was 9.9% (95% confidence 
interval (CI): 7.9–11.9%), with a substantially higher CFR of 
76.8% (95% CI: 61.9–91.7%) among grade 3 NE (Table 5). In 
NMR level 2, the pooled neonatal CFR was 10.7% (95% CI: 
7.6–13.7%) and among grade 3 cases, CFR was 47.9% (95% 
CI: 36.2–59.5%). In NMR level 3, pooled neonatal CFR for 
all NE was higher at 27.7% (95% CI: 18.7–36.6%) and nota-
bly higher for grade 3 NE at 91.8% (83.4–99.4%). Given the 
sparser neonatal CFR data by NE grade as well as incidence 
by NE grade, the pooled estimates for the average all-grade 
NE CFR were used for our estimates.
Estimates of NE case fatality and postneonatal survivors 
of NE. CFR from NE depends largely on access to neonatal 
care to treat complications. Almost all of our data on neona-
tal case fatality arose from tertiary care hospitals, neonatal 
intensive care units, or in populations with high-level access 
to this care, and thus likely underestimate the NE case fatality 
at a global level. In most LMICs, access to neonatal intensive 
care is limited for both facility and home births. In countries 
with <70% facility birth rate, we have estimated that <5% of 
infants born in facilities have access to neonatal intensive 
care, whereas for countries with 70–90% facility birth rates, 
25–50% of infants may have access to neonatal intensive 
care (60). Furthermore, 50 million births occur outside of 
facilities annually (61), and most of these take place without 
a skilled birth attendant or access to neonatal intensive care 
unit. Case fatality among babies with NE is expected to be 
much higher in these settings, as demonstrated by the one 
community-based study from Nepal where neonatal CFR 
was nearly 50% (55).
With these caveats and limitations, we estimate that 
287,000 (181,000–440,000) infants diagnosed with NE 
related to intrapartum events died during the first month of 
life in 2010, leaving 865,000 neonatal survivors (Table 6). 
These estimates are likely underestimates in LMICs, where 
access to neonatal intensive care is low. Importantly, these 
numbers do not account for the intrapartum-related deaths 
in babies who die shortly after birth and before onset of NE, 
notably where there is no resuscitation. Those deaths will also 
appear in mortality registrations as deaths from birth trauma 
or “birth asphyxia.” Impairment in newborns who survive 
the first few hours of life is considered to occur in those who 
develop identifiable NE.
Step 3: calculation of the number of postneonatal Survivors 
with impairment
Risk of NDI among NE survivors. The majority of data on 
morbidity and long-term NDI were from low NMR settings 
(30/47 data sets on moderate-to-severe NDI and 9/17 on mild 
NDI) (Supplementary Information online). Given the sub-
stantially lower data availability disaggregating impairment 
rates by three NE grades (<50% of data identified), we pooled 
data on impairment rates for all grades of NE. Some studies 
reported follow-up for only NE cases that were graded as com-
bined moderate-to-severe. For comparability between studies, 
it was assumed that 30% of all NE would have been mild or 
stage 1, with zero impairment rate, based on our literature 
review and a recent meta-analysis (20). Thus, for these studies, 
to account for attenuation of the impairment rate if mild-stage 
1 cases had been represented in the data, the impairment rate 
was reduced by 30%. For intervention studies, particularly 
therapeutic hypothermia trials, impairment rates were used 
from the control arm (noncooling).
In NMR level 1, there were 29 studies (n = 1,482 NE sur-
vivors) included in the meta-analysis, with follow-up ranging 
from 1 to 10 y (Table 5). A pooled estimate of 26% of survivors 
of NE developed moderate-to-severe NDI (95% CI: 22–31%) 
(Figure 6). For mild NDI, eight studies were identified (n = 
384 NE survivors) mostly reporting intellectual/cognitive 
impairment, and pooled estimate was 14% (95% CI: 9–19%) 
(Figure 7). In NMR level 2–3, there was a total of 16 studies 
identified (n = 858 NE survivors) with follow-up ranging from 
6 mo to 12 y for moderate-to-severe NDI, and 9 studies (n = 
533 NE survivors) that assessed mild NDI up to 10 y. A pooled 
estimate of 27% (95% CI: 20–34%) of infants with NE devel-
oped moderate-to-severe NDI (Figure 8), whereas 21% (95% 
CI: 10–32%) developed mild NDI (Figure 9).
Estimates of the number of NE survivors with NDI. Globally in 
2010, there were an estimated 413,000 impaired survivors of 
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NE, 233,000 (163,000–342,000) with moderate-to-severe NDI, 
and 181,000 (82,000–319,000) with mild NDI. The major-
ity of cases of impairment were concentrated in Asia (South, 
East, Southeast, and Pacific) (108,000 with moderate-to-severe 
NDI; 84,000 with mild NDI) and sub-Saharan Africa (93,000 
cases with moderate-severe NDI; 73,000 with mild NDI). See 
Figure 10 for regional summary.
GBD2010-Specific Inputs and Results
In order to calculate the prevalence of NE survivors across differ-
ent age groups beyond the first month of life, additional data on 
the excess postneonatal mortality risk survivors were required. 
Mortality among children with NE occurs primarily during the 
neonatal period, although there is an ongoing excess risk beyond 
the neonatal period and first year of life. There were three longi-
tudinal NE cohorts from NMR level 1, which reported NE case 
fatality up to 8 y. In the United Kingdom, Levene et al. (15) fol-
lowed up a cohort of 126 newborns with NE; neonatal case fatal-
ity was 9%, whereas case fatality at 2.5 y was 11%. In Canada, 
Finer and colleagues and Robertson and colleagues followed a 
cohort of 226 infants for 8 y; the NE case fatality was 7% at 1.5 
y, 12% at 3.5 y, and 13% at 8 y (62–65). In Australia, Badawi and 
colleagues (66,67) provided a 5-y follow-up for a birth cohort of 
276 NE cases; neonatal case fatality was 9%, 1.5-y case fatality 
was 12%, and 5-y case fatality was 13%. In the single report from 
a developing country, case fatality was substantially higher. Ellis 
et al. (68) followed up 131 newborns with NE identified in the 
principal maternity hospital in Kathmandu, Nepal, up to 1 y. The 
neonatal case fatality was 33%, and at 1-y follow-up, it was 44%.
However, the NE-specific studies had cohort follow-up only 
for a short part of the total life span (up to 8 y) and there-
fore could not be used as the sole sources of mortality risk for 
the longer term estimation of YLD for moderate-to-severe 
impairment in the GBD. Therefore, for the GBD2010 model, 
the excess mortality estimation also used eight studies that 
reported on long-term mortality risk in cerebral palsy which 
had much longer term follow-up (69–76).
Estimates of the number of YLDs and DALYs associated 
with intrapartum conditions/NE. DisMod-MR estimated 
50.2 million DALYs (40.5–59.8) (7,40) worldwide in 2010 
for intrapartum-related NE (Table 6), accounting for 2.0% of 
the GBD. This was a reduction from 1990 when 60.6 million 
DALYs (50.2–75.0) were estimated (2.4% of GBD). South Asia 
Figure 6. Meta-analysis of 29 studies (1,482 neonatal encephalopathy (NE) survivors) reporting moderate/severe impairment for infants with NE in 
countries with neonatal mortality rate <5 per 1,000 (level 1). Study name = country and median year of study. Citations: Australia (1989) (115), Australia 
(1995) (67), Australia (1996) (116), Canada (1993) (31), France (2000) (117,118), Ireland (2004) (118), Italy (1998) (119), Italy (2001) (120), Italy (2004) 
(58), Italy (2005) (121), Multi-country (2001) (122), Multi-country (2004) (105), Multi-country (2004) (107), Netherlands (1995) (123), Netherlands (1998) 
(124), Netherlands (2001) (125), New Zealand (1998) (126), New Zealand (1998) (127), Singapore (1994) (128), Sweden (1985) (59), Sweden (1988) (53), 
Switzerland (1981) (129), Switzerland (1994) (130), United Kingdom (1994) (51), United Kingdom (1997) (131), United Kingdom (2004) (106), United States 
(1997) (132), United States (1999) (133), United States (2002) (134).
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Overall
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0.12 (0.04, 0.21)
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0.42 (0.23, 0.55)
0.20 (0.11, 0.28)
0.35 (−0.12, 0.82)
0.38 (0.21, 0.54)
0.09 (−0.08, 0.26)
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0.24 (0.12, 0.37)
0.12 (0.05, 0.19)
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0.14 (0.07, 0.21)
0.36 (0.23, 0.49)
0.25 (0.17, 0.33)
0.23 (0.13, 0.34)
0.64 (0.35, 0.92)
0.26 (0.14, 0.37)
0.29 (0.22, 0.31)
2.27
4.91
3.60
4.23
4.50
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3.36
4.42
4.08
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4.44
0.74
2.96
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3.63
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3.63
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2.42
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4.69
3.61
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1.61
3.81
100.00
Note: Weights are from random effects analysis
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(21.0 million) and sub-Saharan Africa (15.0 million) had the 
highest burden in 2010.
For NE disability, there were an estimated 6.1 million 
(4.5–8.0) YLDs attributed to NE in 2010 (12% of DALYs) 
as compared with 5.6 million YLDs (4.1–7.2) in 1990. The 
highest numbers of YLDs were in South Asia (2.1 million) 
and East Asia/Pacific (1.5 million). YLDs comprised the 
highest proportion of DALYs in high-income regions (32%) 
Figure 8. Meta-analysis of eight studies (384 neonatal encephalopathy (NE) survivors) reporting mild cognitive impairment for infants with NE for coun-
tries with neonatal mortality rate <5 per 1,000 (level 1). Study name = country and median year of study. Citations: Italy (2005) (121), Netherlands (1995) 
(123), New Zealand (1998) (126), Sweden (1985) (59), United Kingdom (1997) (131), United Kingdom (2004) (106), United States (1999) (133), United States 
(2002) (134).
Study
ID Proportion (95% Cl)
%
Weight
Note: Weights are from random effects anlysis
−0.648 0 0.648
France (2000)
Italy (2005)
New Zealand (1998)
Sweden (1985)
United Kingdom (1997)
United Kingdom (2004)
United States (1999)
United States (2002)
Overall
0.09 (0.02, 0.16)
0.12 (0.01, 0.16)
0.09 (−0.08, 0.26)
0.33 (0.19, 0.47)
0.17 (0..07, 0.27)
0.09 (0.04, 0.14)
0.36 (0.08, 0.65)
0.13 (0.04, 0.23)
0.14 (0.09, 0.19)
18.38
12.56
6.98
9.18
13.51
21.73
2.97
14.70
100.00
Figure 7. Meta-analysis of 16 studies (858 neonatal encephalopathy (NE) survivors) reporting moderate/severe impairment for infants with neonatal 
encephalopathy from countries with neonatal mortality rate ≥5 per 1,000 (level 2–3). Study name = country and median year of study. Citations: Australia 
(1986) (135), Canada (1980) (136), Canada (1980) (62), Canada (1985) (19), China (2004) (137), China (2005) (138), China (2009) (139), China–Hong Kong 
(1986) (140), India (after 1990) (141), Ireland (1983) (142), Italy (1988) (143), Nepal (1995) (68), Serbia (1994) (144), South Africa (1997) (17), Tanzania (2002) 
(145), Turkey (1995) (146).
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and middle-income regions—East Asia/Pacific (21%) and 
North Africa/Middle East (21%). Whereas YLDs were a 
small proportion of total DALYs in sub-Saharan Africa (9%) 
and South Asia (9%).
discussion
Our estimates underline the huge global public health bur-
den related to childbirth complications (Figure 11). In 2010, 
intrapartum-related hypoxic events resulted in 510,000 (44)–
717,000 (6) neonatal deaths, 1.15 million new cases of NE 
and 413,000 impaired survivors. These are the first system-
atic estimates of impairment after intrapartum complications, 
including 233,000 children with severe neurodevelopmental 
 outcomes, often cerebral palsy, and the equally important 
milder impairment outcomes affecting cognitive potential 
among 21% of NE survivors. Over 95% of the deaths and 
impairment occurred in LMICs, depriving the poorest coun-
tries of development potential. Newborn boys are at increased 
risk. In addition, an estimated 54% of ~255,000 maternal 
deaths are intrapartum related (44). Importantly, an estimated 
Figure 9. Meta-analysis of nine studies (533 neonatal encephalopathy (NE) survivors) reporting mild cognitive impairment for infants with neonatal 
encephalopathy for countries with neonatal mortality rate ≥5 per 1,000 (level 2–3). Australia (1986) (135), Canada (1980) (62), Canada (1985) (19), China 
(2004) (137), China–Hong Kong (1986) (140), India (after 1990) (141), Nepal (1995) (68), Serbia (1994) (144), South Africa (1997) (17).
Study
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%
Weight
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0.17 (0.09, 0.25)
0.58 (0.48, 0.69)
0.27 (0.16, 0.37)
0.14 (0.03, 0.25)
0.56 (0.42, 0.70)
0.07 (0.00, 0.14)
0.07 (0.02, 0.12)
0.03 (−0.03, 0.08)
0.21 (0.10, 0.32)
10.78
11.36
10.93
10.89
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100.00
Figure 10. Regional burden of intrapartum-related stillbirths, neonatal deaths, and neonatal encephalopathy outcomes for babies affected by intrapar-
tum-related events in 2010.
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1.2 million intrapartum stillbirths are not counted in GBD or 
any global metrics (8).
These data show that babies may be born into three very differ-
ent worlds. In high-income countries, major intrapartum injury 
has become rare with intrapartum stillbirth rates of under 0.1 
per 1,000 births in some Nordic countries and very few neonatal 
deaths from these complications. We estimated a low NE inci-
dence of 1.6 cases per 1,000 live births in high-income regions 
(19,000 new cases annually). Although intrapartum mortality 
has substantially declined, long-term impairment among sur-
vivors remains an important issue. The recent International 
Liaison Committee on Resuscitation and National Institute for 
Health and Clinical Excellence recommendations (77,78) on 
therapeutic hypothermia are based on head and body cooling 
trials demonstrating significantly lower rates of mortality and 
major impairment among survivors (79).
In contrast, in low-income countries, 50 million home births 
occur annually without skilled birth care (80), and many facility 
births occur in settings with poor quality of intrapartum care and 
poor access to neonatal intensive care (11,81). Intrapartum still-
birth and NMRs are 20–50-fold higher comparing the lowest to 
highest income countries (2). Without access to neonatal resus-
citation, the majority (~60%) of intrapartum “asphyxia” deaths 
occur shortly after birth, before infants develop NE (Figure 1), 
and impairment rates are lower than previously estimated. 
Almost three-quarters (862,000 annually) of all NE cases occur 
in sub-Saharan Africa (14.9/1,000 live births) and South Asia 
(10.4/1,000 live births). These estimates likely underestimate the 
burden in low-income countries, where NE diagnosis requires 
neonatal assessment by a physician. Furthermore, our estimates 
of neonatal case fatality among cases of NE should be cautiously 
interpreted, as these estimates are primarily based on data from 
tertiary care facilities and may therefore significantly also under-
estimate NE deaths in settings with high rates of home births 
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1.2 million intrapartum stillbirths are not counted in GBD or 
any global metrics (8).
These data show that babies may be born into three very differ-
ent worlds. In high-income countries, major intrapartum injury 
has become rare with intrapartum stillbirth rates of under 0.1 
per 1,000 births in some Nordic countries and very few neonatal 
deaths from these complications. We estimated a low NE inci-
dence of 1.6 cases per 1,000 live births in high-income regions 
(19,000 new cases annually). Although intrapartum mortality 
has substantially declined, long-term impairment among sur-
vivors remains an important issue. The recent International 
Liaison Committee on Resuscitation and National Institute for 
Health and Clinical Excellence recommendations (77,78) on 
therapeutic hypothermia are based on head and body cooling 
trials demonstrating significantly lower rates of mortality and 
major impairment among survivors (79).
In contrast, in low-income countries, 50 million home births 
occur annually without skilled birth care (80), and many facility 
births occur in settings with poor quality of intrapartum care and 
poor access to neonatal intensive care (11,81). Intrapartum still-
birth and NMRs are 20–50-fold higher comparing the lowest to 
highest income countries (2). Without access to neonatal resus-
citation, the majority (~60%) of intrapartum “asphyxia” deaths 
occur shortly after birth, before infants develop NE (Figure 1), 
and impairment rates are lower than previously estimated. 
Almost three-quarters (862,000 annually) of all NE cases occur 
in sub-Saharan Africa (14.9/1,000 live births) and South Asia 
(10.4/1,000 live births). These estimates likely underestimate the 
burden in low-income countries, where NE diagnosis requires 
neonatal assessment by a physician. Furthermore, our estimates 
of neonatal case fatality among cases of NE should be cautiously 
interpreted, as these estimates are primarily based on data from 
tertiary care facilities and may therefore significantly also under-
estimate NE deaths in settings with high rates of home births 
and health systems without viable networks of transport and 
referral to specialty care. In a rural community–based setting in 
Nepal, 39% of newborns with probable intrapartum-related NE 
died before they were ever visited by a health worker (55).
Between the “first world” and the “third world” lie a number 
of middle-income, emerging economies, where neonatal care is 
improving, and mortality is declining (81), yet our data and the 
papers in this supplement on preterm outcomes (60) and reti-
nopathy of prematurity (82) also suggest that there is a hidden 
burden of impairment. In these settings, the inappropriate appli-
cation of technological interventions, such as induction of labor 
without adequate intrapartum monitoring or cooling interven-
tions may likely result in higher rates of impaired survivors. 
YLDs comprise a larger proportion of total DALYs in these set-
tings (21% in East Asia/Pacific and Middle East/North Africa, 
vs. 9% in sub-Saharan Africa/South Asia). Over half of the global 
total of impaired survivors were in Latin America/Caribbean, 
Eastern Europe/Central Asia, Middle East/North Africa, and 
East/Southeast Asia/Pacific, where NE incidence ranged from 
4.0 to 6.2 per 1,000 live births. Urgent focus is required to track 
these outcomes and assess prevention strategies, notably quality 
of obstetric and neonatal care, in these settings.
Comparing the various estimates of intrapartum-related neo-
natal mortality, our CFR-based approach suggests that 287,000 
deaths occur among babies with NE annually. However, these 
results should be cautiously interpreted since CFR-based esti-
mates are more uncertain than multi-cause mortality data 
approaches. These estimates of NE deaths are likely an under-
estimate in LMICs. In addition to the aforementioned under-
diagnosis issues the case fatality data were based primarily on 
neonatal intensive care unit cohorts, and access to neonatal 
intensive care is lower in these settings. However, these are still 
consistent with estimates of total intrapartum-related neonatal 
deaths in 2010 (717,000 (UR 610,000–876,000) (6) or 510,000 
Figure 11. Summary of deaths and disability outcomes that are intrapartum related based on 125 million births worldwide in 2010. Sources: intrapartum 
stillbirth estimate (8), neonatal deaths (6). Neonatal encephalopathy (NE) cases, mortality, and impairment outcomes are derived from the estimation 
process described in this article.
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(UR 400,000–620,000) (44)) (Figure 11) since most intrapar-
tum deaths happen soon after birth before the onset of NE, par-
ticularly in low-income countries with poor obstetric care and 
access to resuscitation. NE only develops at several hours of age 
since it is a manifestation of brain injury and inflammation.
A consistent male predominance among NE cases was 
observed in this systematic review, across different regions 
and levels of care. We adjusted for population-based sex 
ratios at birth but were not able to account for potential 
biases in care-seeking for male infants. Male infants may 
be of larger fetal size and predisposed to obstructed labor. 
Males may also be more vulnerable to hypoxic ischemic brain 
injury due to hormonal modulation by testosterone and sex-
specific genetic differences in apoptosis (83). Finally, there 
may be a sex-specific difference in maturation of the ventila-
tory response to hypoxia.
Although the burden of disease is large, we estimated a 
steady 0.9% annual reduction in global NE incidence from 
1990 to 2010. Rates of decline of global neonatal deaths and 
intrapartum-related neonatal deaths are slightly higher, ~2% 
annually from 2000 to 2010. These declines are likely cor-
related with improved access to intrapartum care and facil-
ity birth rates achieved globally over the past two decades. 
The few available historical data in our review demonstrated 
similar rates of decline for mortality in several high-income 
countries since the 1980s (51,53). This fits with the overall 
picture for the global burden of neonatal conditions, with 
most of the limited reduction being due to mortality reduc-
tion, and inadequate morbidity trend data from the highest 
burden countries impeding detailed analysis of time trends 
for impairment (11,84).
The recent literature from therapeutic hypothermia trials 
increased the data inputs on long-term impairment following 
NE/HIE for this systematic review. A meta-analysis of six studies 
by van de Riet et al. (21) reported neurologic disability accom-
panied by severe cognitive impairment among <0.5% of survi-
vors with grade 1, 30% with grade 2, and 84% of grade 3 NE. Pin 
et al. (20) conducted a meta-analysis (2008) including 13 studies 
and reported that 47% (95% CI: 36–57%) of all stages of “post-
asphyxial” NE had death, cerebral palsy, or motor/cognitive 
impairment >2 SD below the norm. Our meta-analysis included 
substantial new data and showed higher neonatal CFRs in high 
mortality settings (27.7% in NMR level 3 vs. 9.9% in NMR level 
1; including 31 studies and 2,639 NE cases), but similar rates 
of moderate-to-severe NDI among NE survivors (27% in NMR 
level 3 vs. 26% NMR level 1; 45 studies and 2,340 NE survivors).
Data Limitations
The most important limitation was the lack of data from 
the highest mortality settings, the inverse data law (84,85). 
Furthermore, almost all of the studies identified were from 
referral-level facilities or neonatal intensive care units. Data 
selected from these settings may be biased with respect to NE 
incidence, staging, case fatality, and impairment, as mothers 
and infants who attend these facilities will not be representa-
tive of the general population.
The shifting terminology and definitions of “birth asphyxia” 
and NE or HIE add specific challenges for comparability (22). 
We included studies that specified criteria for probable intra-
partum-related events, although these definitions also varied 
widely (requirement of fetal distress, degree of acidosis, tim-
ing and cutoff of Apgar scores, requirement of resuscitation, 
and neuroimaging), and our model adjusted the incidence of 
studies that reported NE without specifying evidence of an 
intrapartum insult. The limited data on incidence and outcome 
separated by NE staging, particularly in higher mortality set-
tings, was another limitation.
The variability in disability assessment was substantial. 
Differing definitions, domains, timing, and tools are prob-
lematic and also affected by postneonatal excess mortality and 
losses to follow-up (84). Losses to follow-up over 30% were 
excluded from this analysis.
Data Improvement
As discussed in detail in a separate paper of this supplement 
(84), there is a need for standardized, well-defined minimum 
perinatal data sets including main pregnancy outcomes and 
impairment outcomes. Standardization of impairment out-
comes using validated definitions of specific domains would 
reduce heterogeneity and allow pooling of data. Furthermore, 
conducting assessment at standardized ages/stages in devel-
opment and using common, validated assessment tools are 
critical.
With effective intrapartum interventions increasingly avail-
able in LMICs, it is critical to improve measurement of impact 
and process. Infants born with severe respiratory depression 
are frequently misclassified as stillbirths, particularly in set-
tings where newborns are not routinely assessed at the time of 
birth and even within facilities. Classification as stillbirth may 
be a simple lack of assessment or may be to avoid culpability, 
circumvent the requirement of a death certificate, or in cases of 
neonaticide (2). Three studies of neonatal resuscitation (86–88) 
have demonstrated substantial reductions in “fresh stillbirth” 
rates after training, with reductions ranging from 25 to 45%. A 
critical component of resuscitation training is newborn assess-
ment, thus the reduction in misclassification of depressed live 
born babies as stillbirths was probably the major factor leading 
to overall reductions in stillbirth rates. Nonetheless, two stud-
ies showed reductions in stillbirths without increases in early 
neonatal mortality (86,88), and one showed reductions of both 
stillbirth and day 1 neonatal mortality (87). These demonstrate 
that substantial reductions in overall intrapartum-related mor-
tality can be achieved with resuscitation training in LMIC set-
tings. A composite measure of intrapartum mortality has been 
suggested by United Nations Population Fund that combines 
intrapartum stillbirth with day 1 neonatal deaths (2) but has 
yet to be clearly defined and tested.
The measurement of disability becomes increasingly impor-
tant with declines in intrapartum-related mortality. The first 
critical step is the consistent use of NE definitions and clas-
sification for staging. Furthermore, standardized criteria 
are required to define “intrapartum-related” events. Even 
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in low-income or community settings, data on certain risk 
factors strongly associated with intrapartum hypoxic insult 
could be more routinely collected: for example, conditions 
such as nonvertex presentation, multiple birth and prolonged/
obstructed labor, and maternal pyrexia particularly when 
associated with signs of dystocia. The development of simpli-
fied, validated definitions of NE that could be ascertained at 
the community level or on verbal autopsy may help to better 
quantify the burden in low-income settings. A breech presen-
tation baby who develops seizures shortly after birth with per-
sistent poor feeding and abnormal tone maybe diagnosable by 
a community health worker or even maternal report.
Program Implications
The prevention of intrapartum-related conditions can be 
approached at three levels:
1. the primary prevention of intrapartum hypoxic injury 
during labor and childbirth,
2. secondary prevention of mortality, morbidity, and 
long-term impairments among infants who have 
experienced a hypoxic intrapartum event or develop 
NE, and
3. tertiary prevention with improved identification and 
care of infants with disability.
table 8. Research findings and implications of the burden of intrapartum-related neonatal encephalopathy and impairment 
data findings
  Neonatal encephalopathy (NE) may be due to various causes. Given 50 million home births, almost all without skilled care (80), and the limitations around 
recognition and prompt intervention for fetal compromise, even when it occurs in a LMIC health facility, the major contributing factor is intrapartum 
hypoxic injury. National estimates of causes of neonatal deaths are now undertaken routinely and suggest three-quarters of a million intrapartum-
related neonatal deaths worldwide (6). Intrapartum stillbirths are not counted in global metrics, but recent estimates suggest 1.2 million deaths (8).
 These are the first estimates of NE related to intrapartum events and subsequent outcomes, showing inputs and methods.
 • Our modeled NE incidence suggests 1.15 million babies were affected in 2010, down from 1.60 million in 1990 (0.9% annual reduction).
 •  Of these babies with NE, 865,000 survived of which 233,000 (UR 163–342,000) had moderate-severe impairment and 181,000 (UR 82–319,000) had 
mild cognitive or motor impairment.
 •  The severity of NE among incident cases is similar across high- vs. low-income settings; but the case fatality rate is much higher for severe NE in high 
mortality (92%) compared to low mortality (77%) settings.
 •  GBD2010 estimated that in the year 2010 there were 6.9 million years lived with disability (YLDs) associated with intrapartum-related NE 
impairment (accounting for 12% of DALYs). DALYs attributed to intrapartum-related NE accounted for 2.4% of the total GBD. Using consistent 
methods for 1990 and 2010, DALYs attributed to intrapartum-related NE dropped from 60.6 M in 1990 to 50.2 M in 2010, a 17% drop in the number 
of DALYs and a 21% drop in the rate of DALYs taking into account a higher number of births in 2010.
  In settings without widespread availability of maternal and newborn care, the NE-related neonatal CFR is high, and the numbers of disabled survivors 
are fewer than previously believed when estimates were based on data from high-income countries. The low impairment rates in contexts without 
neonatal intensive care are promising for the scale-up of basic neonatal resuscitation programs. Impaired NE survivors do appear to be increasing in 
middle-income settings with intensive care, similar to findings for preterm birth survivors. 
data for action
 Key programs priorities include:
 •  Prevention of intrapartum injury is an important global public health priority, and is resulting in accelerated reduction of maternal mortality 
(4.2% per year), slower reduction in intrapartum-related neonatal deaths (2% per year), but has yet to have major effects on intrapartum stillbirths. 
Immediate burden reduction is possible through increasing coverage and the quality of care around the time of birth, ensuring access to 
emergency obstetric-neonatal care and early postnatal care. Urgent attention is required to ensure that investments in maternal care services also 
equip midwives and other service providers to care for newborns in terms of essential care and resuscitation as well as care of babies with NE.
 •  Basic neonatal resuscitation programs are showing promising results (86,87), and should be scaled up, and it appears that there are relatively few 
survivors with disabilities in the absence of neonatal intensive care units. Identification and care of survivors with disabilities and impairments is an 
increasingly important service provision and planning issue, especially in middle-income countries.
 •  The package of prevention, recognition, and timely intervention for obstetric emergencies; neonatal resuscitation; and availability of regionalized 
transport to neonatal intensive care with specific therapeutic interventions (hypothermia) offers the potential for achieving the lowest rates of NE 
and impairment.
data gaps and improvements
 Major gaps were found in the quantity and the quality of data to inform these estimates including:
  Geographic gaps, especially for high-burden settings and population-based data.
   Inconsistent definitions for NE and especially for impairment outcomes with variable metrics and tools administered at different ages, further 
affected by high loss to follow-up in many cohort studies.
  Solutions:
  • Increased priority for minimum perinatal datasets including all main pregnancy outcomes.
  • Inclusion of stillbirths in global goals and tracking mechanisms.
  • Standardized reporting of impairment outcomes using tools validated across settings (84).
GBD, Global Burden of Disease; LMIc, low- and middle-income countries.
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We have recently reviewed the impact of a wide range 
of interventions to avert intrapartum-related injury in 
the International Journal of Gynecology and Obstetrics 
(80,89–92).
The primary prevention of intrapartum injury is an important 
global public health priority to avert mortality and morbid-
ity and is associated with accelerated reduction of maternal 
mortality (4.2% per year) and a smaller effect on intrapartum 
neonatal deaths (81). Improving the coverage and the quality 
of obstetric care and improving access to emergency obstet-
ric care, particularly for high-risk pregnancies, are key priori-
ties. Comprehensive emergency obstetric care is estimated to 
reduce intrapartum neonatal deaths by 85% (93), and emer-
gency obstetric training has been associated with 50% reduc-
tion in rates of HIE (94). Promising and feasible interventions 
in LMICs include improved intrapartum monitoring by use 
of partographs and identification and management of child-
birth complications including nonvertex presentation, shoul-
der dystocia, multiple pregnancy, and postterm gestation (89). 
Furthermore, the early identification and treatment of mater-
nal intra-amniotic infection is promising given the synergistic 
NE risk with maternal pyrexia/chorioamnionitis and hypoxia 
(95). For the 50 milllion women giving birth at home, invest-
ments in maternal care services must be made to increase 
access and quality and organize transport systems especially 
for obstetric and neonatal emergencies.
Among babies who suffer an intrapartum hypoxic insult, 
basic newborn resuscitation is an effective, feasible secondary 
prevention intervention and reduces intrapartum-related neo-
natal mortality by 30% (96). Training programs, like Helping 
Babies Breathe (97), have been developed, widely implemented, 
and are being scaled up in ~50 countries (87,97,98). Our data 
show overall low rates of impairment in low-income settings 
due to high early mortality, which is relevant for this scale-up, 
suggesting low impairment risk in contexts with only basic 
resuscitation and no intensive care. Preliminary data from the 
First Breath trial found no differences in average Bayley Mental 
Development Index among infants in the resuscitation vs. con-
trol arms (99). However, in middle-income settings, impair-
ment rates are higher, similar to the pattern seen for preterm 
birth survivors (60). More focus must be placed on measuring 
impairment-free survival in these settings (84). Quality of care 
must be emphasized with the wide-scale implementation of 
technological interventions. High oxygen concentration dur-
ing resuscitation is associated with increased risk of mortality 
and impairment and should be avoided (100). Neonatal hyper-
thermia may exacerbate hypoxic brain injury and increase risk 
of apnea (101,102), thus preventing overheating under radiant 
infant warmers is a key intervention in these settings.
For those babies who develop NE, improved care can reduce 
mortality and impairment outcomes. This is an increasingly 
important aspect of service provision and planning, especially 
in middle-income countries (84). Basic supportive neonatal care 
for babies experiencing intrapartum-hypoxic injury has received 
little attention (91). Prompt recognition and treatment of hypo-
glycemia, hyperbilirubinemia, and seizures (103) after potential 
hypoxic–ischemic insult can limit the extent of cerebral injury 
(104). Therapeutic hypothermia may significantly reduce dis-
ability among survivors of NE (32% reduction in major disabil-
ity rates at 18 mo (79,105–107)) and is currently recommended 
as standard of care for infants with moderate-to-severe NE in 
high-income countries (77,78). Initiation within the therapeutic 
window of 6 h of life is critical (108) and emphasizes the impor-
tance of early, rapid diagnosis of NE and timely transport to a 
facility with the capacity to deliver the intervention. Simpler 
methods of identification of infants with NE by health work-
ers in first-level facilities and community settings may facilitate 
early recognition and triage. The development of simpler, low-
cost methods to implement hypothermia in LMICs have been 
piloted and are feasible (109). Some small clinical trials of cool-
ing have been performed in India (110). However, the safe and 
effective administration of therapeutic hypothermia requires a 
high level of intensive care support with equipment for blood 
pressure monitoring, recognition and prompt treatment of 
infection, regular assessment of blood gases to ensure normo-
capnia and normoxia (111), and appropriate sedation (112).
Tertiary prevention involves earlier identification and 
care of children with disabilities, as well as family support. 
Furthermore, the role of early neurocognitive stimulation 
interventions should be considered in these infants (113). 
As part of the Global Network study in rural India, Pakistan, 
and Zambia, Carlo et al. (114) showed that the implementa-
tion of an early developmental intervention by parents with 
biweekly home visits by trainers resulted in significantly higher 
Mental Development Index scores on the Bayley Scale at 3 y 
of age. Intrapartum care and care of affected babies should be 
addressed in early childhood development strategies that have 
traditionally focused on infant nutrition. This is further dis-
cussed elsewhere in the supplement (84).
Conclusion
These are the first systematic global estimates of NE and subse-
quent neurodevelopmental impairment (see Table 8 for sum-
mary of findings). Our mortality estimate for NE is lower than 
current global estimates of the total intrapartum-related neo-
natal deaths, because many nonbreathing babies currently die 
without resuscitation and prior to manifesting NE. Our impair-
ment estimate is also lower than previous GBD work, mainly 
because of more data showing a high CFR in cases of NE in 
the absence of intensive care. Hence, the number of impaired 
survivors is lower than previously believed, but still substantial 
in LMICs, where 27% of NE survivors are affected with a mod-
erate-to-severe impairment (233,000 infants) and 21% of NE 
survivors (181,000 infants) with a mild impairment, under-
lining the effects on a child’s long-term potential for school 
learning, academic achievement, and economic productivity. 
Intrapartum-related conditions in live born babies result in 50 
million DALYs, 2% of all GBD2010. There are also 1.2 million 
intrapartum stillbirths not counted in GBD. Universal cover-
age of obstetric care and neonatal resuscitation would prevent 
most of this burden. Investment in  quality care at birth is criti-
cal. Missing data on stillbirths, neonatal deaths, and long-term 
overview, and relevant findings from the Global Burden of Disease study. 
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impairment means that we fail to appreciate the full extent of 
the burden, undervalue the effect of these investments, and 
miss the opportunity to achieve our goal of impairment-free 
survival and improved development and economic potential.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at 
http://www.nature.com/pr
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